Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 18;8(4):194.
doi: 10.3390/pathogens8040194.

Antigenic Site Variation in the Hemagglutinin of Pandemic Influenza A(H1N1)pdm09 Viruses between 2009-2017 in Ukraine

Affiliations

Antigenic Site Variation in the Hemagglutinin of Pandemic Influenza A(H1N1)pdm09 Viruses between 2009-2017 in Ukraine

Oksana Zolotarova et al. Pathogens. .

Abstract

The hemagglutinin (HA) is a major influenza virus antigen, which, once recognized by antibodies and substitutions in HA genes, helps virus in escaping the human immune response. It is therefore critical to perform genetic and phylogenetic analysis of HA in circulating influenza viruses. We performed phylogenetic and genetic analysis of isolates from Ukraine, the vaccine strain and reference strains were used to phylogenetically identify trends in mutation locations and substitutions. Ukrainian isolates were collected between 2009-2017 and clustered in the influenza genetic groups 2, 6, 7, and 8. Genetic changes were observed in each of the antigenic sites: Sa - S162T, K163Q, K163I; Sb - S185T, A186T, S190G, S190R; Ca1 - S203T, R205K, E235V, E235D, S236P; Ca2 - P137H, H138R, A141T, D222G, D222N; Cb - A73S, S74R, S74N. In spite of detected mutations in antigenic sites, Ukrainian isolates retained similarity to the vaccine strain A/California/07/09 circulated during 2009-2017. However, WHO recommended a new vaccine strain A/Michigan/45/2015 for the Southern Hemisphere after the emergence of the new genetic groups 6B.1 and 6B.2. Our study demonstrated genetic variability of HA protein of A(H1N1)pdm09 viruses isolated in 2009-2017 in Ukraine. Influenza surveillance is very important for understanding epidemiological situations.

Keywords: antigenic site; genetic analysis; influenza A(H1N1)pdm09 virus; mutation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Phylogenic comparison of A(H1N1)pdm09 influenza virus in 2009–2017 based on oligonucleotide sequences of hemagglutinin (HA) conducted by the Neighbor Joining method, Kimura 2-parameter model with 1,000 bootstrap replications.
Figure 2
Figure 2
Spread of A(H1N1)pdm09 influenza virus of genetic groups 6B.1 and 6B.2 in the early 2015–2016 season and in the late 2016–2017 season in the world (data provided by NextFlu – now Nextstrain https://nextstrain.org/) [18,19].
Figure 3
Figure 3
Location of amino acid substitutions in antigenic sites of HA viruses of A(H1N1)pdm09 influenza discovered among isolates isolated in Ukraine between 2009 and 2017 (PDB ID–3LZG).

References

    1. Ramos A., Herrera B., Ramirez O., García A.A., Jiménez M.M., Valdés C.S., Fernández A.G., González G., Fernández S.I., Báez G.G., et al. Molecular and phylogenetic analysis of influenza A H1N1 pandemic viruses in Cuba, May 2009 to August 2010. Int. J. Infect. Dis. 2013;17:565–567. doi: 10.1016/j.ijid.2013.01.028. - DOI - PubMed
    1. Barrero P.R., Viegas M., Valinotto L.E., Mistchenko A.S. Genetic and Phylogenetic Analyses of Influenza A H1N1pdm Virus in Buenos Aires, Argentina. J. Virol. 2011;85:1058–1066. doi: 10.1128/JVI.00936-10. - DOI - PMC - PubMed
    1. Thyagarajan B., Bloom J.D. The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin. eLife. 2014;3:e03300. doi: 10.7554/eLife.03300. - DOI - PMC - PubMed
    1. Goneau L.W., Mehta K., Wong J., L’Huillier A.G., Gubbay J.B. Zoonotic Influenza and Human Health-Part 1: Virology and Epidemiology of Zoonotic Influenzas. Curr. Infect. Dis. Rep. 2018;20:37. doi: 10.1007/s11908-018-0642-9. - DOI - PubMed
    1. Parida M., Dash P.K., Kumar J.S., Joshi G., Tandel K., Sharma S., Srivastava A., Agarwal A., Saha A., Saraswat S., et al. Emergence of influenza A(H1N1)pdm09 genogroup 6B and drug resistant virus, India, January to May 2015. Euro. Surveill. 2016;21:1–6. doi: 10.2807/1560-7917.ES.2016.21.5.30124. - DOI - PubMed

LinkOut - more resources